ImmunityBio, Inc.
SAN DIEGO, CA · CIK 0001326110 · Biotech · Public
Investigational immunotherapy and cell therapy products targeting cancer
immunitybio.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $633M
- 8 Form D · Sep 2023
- 37 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 16 granted · 24 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200820102012201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $425,700 | |
| Private capital raised | Form D · SEC | $6,504,875 | |
| Private capital raised | Form D · SEC | $10,000,000 | |
| Private capital raised | Form D · SEC | $47,495,481 | |
| Private capital raised | Form D · SEC | $71,004,041 | |
| Private capital raised | Form D · SEC | $17,000,000 | |
| Private capital raised | Form D · SEC | $10,656,035 | |
| Private capital raised | Form D · SEC | $469,986,600 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1806 | Andon Bio Inc. | — | $250K |
| 1807 | Chia Inc. | — | $28M |
| 1808 | Future Path Medical Holding Company, LLC | — | $2.6M |
| 1809 | ImmunityBio, Inc. | — | $633M |
| 1810 | MODERN MEADOW | — | $53M |
| 1811 | Sapience Therapeutics Inc. | — | $8.3M |
| 1812 | Marius Pharmaceuticals, LLC | — | $5.6M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Richard AdcockDirector · Executive Officer
- Michael BlaszykDirector
- John BrennanDirector
- Wesley ClarkDirector
- Cheryl CohenDirector
- Richard GombergExecutive Officer
- Steve GorlinDirector
- Steven GorlinDirector
- Ronald HerbermanDirector
- Henry JiDirector
- Henry Ji, Ph.D.Director
- Hans KlingemannDirector
- Hans Klingemann, M.D., Ph.D.Director
- Hans KlingermannDirector
- Richard KusserowDirector
- Linda MaxwellDirector
- John PottsDirector
- John Potts, Jr., M.D.Director
- Robert RosenDirector
- David SachsExecutive Officer
- Christobel SeleckyDirector
- Barry SimonDirector · Executive Officer
- Barry Simon, M.D.Director · Executive Officer
- Patrick Soon-ShiongDirector · Executive Officer
- Patrick Soon-Shiong, M.D.Director · Executive Officer
- John ThomasDirector
- John Thomas, Jr.Director
Patents
- Methods for Preparing and Storing Immortalized Cytolytic Natural Killer Cellsapplication
- Anktiva and Lymphocyte Rescue Compositions and Methodsapplication
- Quadricistronic System Comprising A Homing Receptor And Chimeric Antigen Receptor For Stable Genetic Modification Of Cellular Immunotherapiesapplication
- Distributed Ledger For Medicament Administration Trackinggranted
- Multi-chain Chimeric Polypeptides And Uses Thereofgranted
- Compositions and Methods for NK-92 Cells Expressing Native CD16granted
- Methods Of Reducing Neuroinflammationapplication
- Elimination Of PD-L1-POSITIVE Malignancies By PD-L1 Chimeric Antigen Receptor-expressing Nk Cellsapplication
- Interleukin-15, PD-1 Antibodies, and Taxanes in Non-Small Cell Lung Cancerapplication
- Intratumorally Injected Yeast Vaccineapplication
- NK-92 Cells with Cytokine Induced Memory-Like Cytotoxicity And Derivatives Thereofapplication
- Methods Of Modulating Circadian Clock Gene Expressionapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.